Aspirin
74,290
Phase 1 small_molecule completed
Quick answer
Aspirin for Bioequivalence is a Phase 1 program (small_molecule) at Protalix BioTherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Protalix BioTherapeutics
- Indication
- Bioequivalence
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed